Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite

June 13, 2019

CHICAGO (TVT2019 – Structural Heart Summit), June 13, 2019 – Materialise, a global 3D printing software and solutions company, has received FDA clearance for its Mimics Enlight cardiovascular planning software suite. The first release will support clinicians planning complex transcatheter mitral valve replacement (TMVR) procedures.

Read more

Fluidda and Materialise Announce Partnership to Develop Personalized Solutions for Lung Patients

April 26, 2019

Fluidda announces a new phase in its collaboration with Materialise, to expand personalized treatment options in the respiratory care, building on its image based software. As part of the partnership, Materialise invests €2.5 million in Fluidda and Wilfried Vancraen, founder and CEO of Materialise, will join the board of directors at Fluidda.

Read more

Materialise and Carestream to Deploy Zero Footprint Surgical Planning Solution

November 27, 2018

PLYMOUTH, Mich., Nov. 27, 2018 – Materialise, in collaboration with Carestream Health, is developing a work-in-progress zero footprint deployment of their pre-operative planning solution for orthopaedists, leveraging Materialise’s OrthoView software. Thanks to enterprise-wide licensing and an enterprise imaging-integrated zero footprint deployment, Materialise and Carestream will be able to give surgeons the freedom to plan procedures in a standard browser, eliminating the requirement for additional software.

Read more

Bring Peace of Mind to Medical 3D Printing with Materialise Certified Solutions

November 26, 2018

CHICAGO – (Nov. 26, 2018). Materialise NV (Nasdaq: MTLS), a world leading 3D printing solutions provider, is working with partners to remove uncertainty and confusion for hospitals and physicians who are incorporating 3D printing into their diagnostic and surgical planning processes.

Materialise has launched a certification program that allows printer manufacturers that partner with the company to have products tested and validated as being fully compatible with Materialise Mimics inPrint software. inPrint is the first and only software to gain clearance from the FDA to develop 3D printed anatomical models for diagnostic and surgical planning uses. The inPrint software is printer- and material-agnostic, allowing Materialise to develop partnerships and solutions to meet a range of hospital and clinician requirements.

Read more

Materialise Strengthens Unique Position in Healthcare Industry with Expanding IP Portfolio

June 19, 2018

Leuven, Belgium – June 19, 2018. Materialise NV (NASDAQ: MTLS) is a world leader in the development of technology enabling personalized healthcare solutions. Materialise’s latest patent, accepted by the Australian Patent Office, concerns Materialise’s 3D planning technologies and 3D-printed guides which enable the design of screw placements for the fit and fixation of customized implants. With the recent expansion of its portfolio of medical patents, Materialise continues to strengthen its unique position in the healthcare industry, supporting its commitment to help patients worldwide through technological innovation.

Read more

Connect with Materialise